Associate Professor of Pediatrics, University Wash

Pediatric Hematology & Oncology

Dr. Dana C. Matthews, MD

Dana C. Matthews works in the field of Pediatric Hematology & Oncology. She received 2 awards: "Super Doctor" and "Top MD". Doctor Dana C. Matthews, MD is a published doctor as well. She has 42 publications published. The latest was: Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models.

Publications

Congenital sideroblastic Anemia due to mutations in the mitochondrial HSP70 homologue HSPA9.
Antithrombin concentrates use in children on extracorporeal membrane oxygenation: a retrospective cohort study.
Inherited Disorders of platelet function.
Fanconi Anemia-like presentation in an infant with constitutional deletion of 21q including the RUNX1 gene.
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients...
Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid Leukemia.
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of Acute myeloid leukemia in first remiss...
Inferior vena cava thrombosis causing Acute cauda equina syndrome. Case report.
Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate model.
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma:...
Conditionally cleavable radioimmunoconjugates: a novel approach for the release of radioisotopes from radioimmunoconjugates.
Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.
Antibody-based therapy of human Leukemia.
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma.
Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh Immune globulin.
The clinical impact of increased sensitivity PT and APTT Coagulation assays.
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.
Targeted therapy for hematologic Malignancies: has its promise been realized?
Barriers to bone marrow transplantation for sickle cell Anemia.
Is there a better way to deliver total body irradiation?
Monoclonal antibodies in the study and therapy of hematopoietic Cancers.
Immunotherapy in Acute myelogenous leukemia and myelodysplastic syndrome.
Current uses of monoclonal antibodies in the treatment of Acute leukemia.
Bone marrow transplantation for sickle cell Disease.
The role of radioimmunotherapy in bone marrow transplantation.
Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced Acute leukemia and myelodysplastic syndrome.
Outcome of allogeneic bone marrow transplantation for children with advanced Acute myeloid leukemia.
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.
The use of radioimmunoconjugates in stem cell transplantation.
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.
The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for Acute myelogenous leukemia.
Allogeneic marrow transplantation for refractory Anemia: a comparison of two preparative regimens and analysis of prognostic factors.
Development of a marrow transplant regimen for Acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cycl...
Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque.
The use of radiolabeled antibodies in bone marrow transplantation for hematologic Malignancies.
Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models.
Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody.
Localization of radiolabeled antimyeloid antibodies in a human Acute leukemia xenograft tumor model.
Immunosuppressive effects of (131)I-anti-CD45 antibody in unsensitized and donor antigen-presensitized H2-matched, minor antigen-mismatched murine transplant models.
Successful unrelated donor cord blood transplantation for Glanzmann''s thrombasthenia.
Use of radiolabeled antibodies in the treatment of childhood Acute leukemia.

Schools

University of Washington
Duke University Med Center
University Wash Chldns Hospital Med Center

Conditions Treated

Acute Leukemia
Adrenal Gland Cancer
Anemia
Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
View All

Doctors Specialties

Pediatric Hematology
Oncology

Accepted Insurances

Awards

Super Doctor
Top MD

Education

Duke University Hospital

Hospital

Seattle Children's Hospital

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Jean E. Sanders, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jenny W. Pang, MD This Doctor is OpenDoctor Recommended.
	Dr. Phoenix A. Ho, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeffrey R. Geyer, MD This Doctor is OpenDoctor Recommended.
	Dr. Tina M. Albertson, MD This Doctor is OpenDoctor Recommended.
	Dr. Brandon K. Hadland, MD This Doctor is OpenDoctor Recommended.
	Dr. Colleen S. Delaney, MD This Doctor is OpenDoctor Recommended.
	Dr. Kelly J. Faucette, MD This Doctor is OpenDoctor Recommended.
	Dr. Barbara E. Small, MD
	Dr. Douglas S. Hawkins, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Thomas J. Manley, MD This Doctor is OpenDoctor Recommended.
	Dr. Blythe Thomson, MD This Doctor is OpenDoctor Recommended.